探討凝血?調節素在乳癌上的臨床診斷及治療上的角色及調控機制(1/3)

Medicine and Dentistry

1. Thrombomodulin 100%
2. Breast Cancer 100%
3. Hormone Therapy 20%
4. Molecular Marker 20%
5. Genetic Marker 20%
6. Malignant Neoplasm 13%
7. Diseases 13%
8. Programmed Cell Death 6%
9. Primary Tumor 6%
10. Epidermal Growth Factor Receptor 6%
11. Oncotype DX 6%
12. Recurrent Disease 6%
13. Vascular Endothelial Cell 6%
14. Glycoprotein 6%
15. Combination Therapy 6%
16. Cancer Pathobiology 6%
17. Gamma Urogastrone 6%
18. Protein P53 6%
19. Clinical Decision Making 6%
20. Cell Cycle 6%
21. Anticoagulation 6%
22. Steroid Receptor 6%
23. Cyclin-Dependent Kinase 6%
24. Lung Cancer 6%
25. Angiogenesis 6%
26. Adjuvant Chemotherapy 6%
27. Cell Proliferation 6%
28. Systemic Therapy 6%
29. Treatment Response 6%
30. Proteasome 6%
31. Cancer 6%
32. Chemotherapy 6%
33. Global Health 6%
34. Therapeutic Target 6%

Pharmacology, Toxicology and Pharmaceutical Science

1. Breast Cancer 100%
2. Thrombomodulin 100%
3. Endocrine Therapy 20%
4. Molecular Marker 20%
5. Malignant Neoplasm 13%
6. Diseases 13%
7. Chemotherapy Regimens 13%
8. Primary Tumor 6%
9. Combination Therapy 6%
10. Glycoprotein 6%
11. Gamma Urogastrone 6%
12. Lung Cancer 6%
13. Steroid Receptor 6%
14. Epidermal Growth Factor Receptor 6%
15. Protein P53 6%
16. Cyclin Dependent Kinase 6%
17. Recurrent Disease 6%
18. Proteasome 6%
19. Systemic Treatment 6%